Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Imanis Life Sciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Imanis Life Sciences

Imanis Life Sciences

Pre-Seed

Imanis: A biotech firm specializing in non-invasive imaging and oncolytic virotherapy.

HQ
Rochester, MN, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Imanis Life Sciences is a biotechnology company focused on providing non-invasive imaging solutions and specializing in oncolytic virotherapy. The company offers a range of products and services, including custom virus and cell solutions, virus assays, and contract research to support the development of oncolytic virus therapies, gene and cell therapies, regenerative medicines, and vaccines. Their mission is to advance scientific excellence in these areas to facilitate groundbreaking medical research and treatments.

Imanis Life Sciences has made significant strides in the biotechnology sector by developing innovative tools and methods that enhance the efficiency and effectiveness of medical research. Their expertise in engineering custom cell lines and validating transgene expression has positioned them as a valuable partner for researchers and pharmaceutical companies. Through their contributions, Imanis has had a notable impact on the advancement of therapies that address critical medical needs.

Imanis Life Sciences - Similar Companies

IconOVir Bio logo

IconOVir Bio

iconovir.com

Imagen Biotech logo

Imagen Biotech

ManaT Bio logo

ManaT Bio

clasptx.com

Imvaq Therapeutics logo

Imvaq Therapeutics

Imunon logo

Imunon

imunon.com

ImCare Biotech logo

ImCare Biotech

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

Unleash Immuno Oncolytics logo

Unleash Immuno Oncolytics

unleash.bio

Mana Therapeutics logo

Mana Therapeutics

IM Therapeutics logo

IM Therapeutics

imtherapeutics.com

Cellomics Technology logo

Cellomics Technology

cellomicstech.com

INmune Bio logo

INmune Bio

inmunebio.com

Inmagene Biopharmaceuticals logo

Inmagene Biopharmaceuticals

inmagenebio.com

Cellular Approaches logo

Cellular Approaches

Imaginab logo

Imaginab

imaginab.com

Imanis Life Sciences - Quick Facts

Who are Imanis Life Sciences' competitors?

Companies similar to Imanis Life Sciences include IconOVir Bio, Imagen Biotech, ManaT Bio and Imvaq Therapeutics.

When was Imanis Life Sciences founded?

Imanis Life Sciences was founded in 2012.

Where is Imanis Life Sciences' headquarters located?

Imanis Life Sciences' headquarters is located in Rochester, MN, US.

When was Imanis Life Sciences' last funding round?

Imanis Life Sciences' most recent funding round was for $1M (USD) in March 2014.

How much has Imanis Life Sciences raised to-date?

As of Mar 24, 2014, Imanis Life Sciences has raised a total of $1M (USD).

How many employees does Imanis Life Sciences have?

Imanis Life Sciences has 41 employees as of Feb 5, 2024.

Imanis Life Sciences - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Cell Therapies
  • Virus Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 8690Other human health activities
Show 22 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified